Drug · DIN 00778869
NITROJECT
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since October 17, 2025; first marketed December 31, 1988.
- Drug Identification Number (DIN)
- 00778869
- Company (DIN owner)
- Juno Pharma Canada Inc.Montreal, Quebec, Canada
- Schedule
- Ethical
- Dosage form
- Solution
- Route
- Intravenous
- Therapeutic class (ATC)
- Glyceryl trinitrate C01DA02
- Class
- Human
- Record last updated
- July 31, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| NITROGLYCERIN | 50 MG | 10 ML |
Notices of Compliance
Health Canada approvals that name this DIN.
- October 17, 2025: NOC 36200New Drug Submission (NDS) · Administrative: Merger/Buy-out. Administrative: Change in manufacturer name. Update to Product Monograph (to align with supporting PM). Update to package labels